• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

立体定向体部放疗(SBRT)后肺部损伤与肿瘤反应:一项CT系列随访研究的结果

Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study.

作者信息

Guckenberger Matthias, Heilman Katrin, Wulf Joern, Mueller Gerd, Beckmann Gabriele, Flentje Michael

机构信息

Department of Radiation Oncology, Julius-Maximilians University, Josef-Schneider-Strasse 11, Wuerzburg, Germany.

出版信息

Radiother Oncol. 2007 Dec;85(3):435-42. doi: 10.1016/j.radonc.2007.10.044. Epub 2007 Nov 28.

DOI:10.1016/j.radonc.2007.10.044
PMID:18053602
Abstract

PURPOSE

To evaluate the CT morphological pattern of tumor response and pulmonary injury after stereotactic body radiotherapy (SBRT) for early stage non-small lung cancer (NSCLC) and pulmonary metastases.

MATERIALS AND METHODS

Seventy patients (lesions n=86) with pulmonary metastases (n=48) or primary early stage NSCLC (n=38) were analyzed. Patients were treated with hypofractionated SBRT (three to eight fractions with a single dose between 6 and 12.5 Gy; n=56) or with radiosurgery (26 Gy; n=30). The pattern and sequence of pulmonary injury and of tumor response was evaluated in 346 follow-up CT studies, 4.9 on average.

RESULTS

Symptomatic pneumonitis was observed in 10% after a median interval of 5 months. No pulmonary reaction was observed in most patients 6 weeks after treatment; spotted-streaky condensations were characteristic between 3 months and 6 months. Dense consolidation and retraction started after 9 months and the fibrotic remodelling process continued for years. Ten targets relapsed after a median of 7 months. At 12 months complete response was seen in 43% and the differentiation of residual tumor from pulmonary reaction was not possible in 33%.

CONCLUSIONS

A typical sequence of pulmonary reactions was observed without differences between hypofractionated treatment and radiosurgery. Onset of pneumonitis was later compared to conventionally fractionated radiotherapy.

摘要

目的

评估立体定向体部放疗(SBRT)治疗早期非小细胞肺癌(NSCLC)及肺转移瘤后肿瘤反应和肺损伤的CT形态学模式。

材料与方法

分析70例患者(共86个病灶),其中肺转移瘤患者48例,早期原发性NSCLC患者38例。患者接受了大分割SBRT(3至8次分割,单次剂量6至12.5 Gy;n = 56)或放射外科治疗(26 Gy;n = 30)。在346次随访CT研究中评估了肺损伤和肿瘤反应的模式及顺序,平均随访4.9次。

结果

10%的患者在中位间隔5个月后出现症状性肺炎。多数患者在治疗6周后未观察到肺部反应;3个月至6个月期间特征性表现为斑片状条纹状实变。9个月后开始出现致密实变和肺组织牵拉,纤维化重塑过程持续数年。10个靶病灶在中位时间7个月后复发。12个月时43%的患者达到完全缓解,33%的患者无法区分残留肿瘤与肺部反应。

结论

观察到典型的肺部反应序列,大分割治疗与放射外科治疗之间无差异。与传统分割放疗相比,肺炎的发生时间较晚。

相似文献

1
Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study.立体定向体部放疗(SBRT)后肺部损伤与肿瘤反应:一项CT系列随访研究的结果
Radiother Oncol. 2007 Dec;85(3):435-42. doi: 10.1016/j.radonc.2007.10.044. Epub 2007 Nov 28.
2
Lung density changes after stereotactic radiotherapy: a quantitative analysis in 50 patients.立体定向放疗后肺密度的变化:50 例患者的定量分析。
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):974-8. doi: 10.1016/j.ijrobp.2010.07.025. Epub 2010 Oct 6.
3
Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation.肺部肿瘤图像引导立体定向体部放射治疗的剂量-反应关系:四维剂量计算的相关性
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):47-54. doi: 10.1016/j.ijrobp.2008.06.1939. Epub 2008 Oct 30.
4
Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.立体定向体部放射治疗可安全用于局部晚期非小细胞肺癌残留病灶的加量治疗:一项前瞻性研究。
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1325-31. doi: 10.1016/j.ijrobp.2012.11.011. Epub 2012 Dec 19.
5
Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.比较有和无病理证实的非小细胞肺癌患者行立体定向体部放疗的结果。
Ther Adv Respir Dis. 2014 Feb;8(1):3-12. doi: 10.1177/1753465813512545. Epub 2013 Dec 10.
6
Radiological changes after stereotactic radiotherapy for stage I lung cancer.立体定向放疗后Ⅰ期肺癌的放射学变化。
J Thorac Oncol. 2011 Jul;6(7):1221-8. doi: 10.1097/JTO.0b013e318219aac5.
7
Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC.螺旋断层放疗用于早期医学上无法手术的非小细胞肺癌立体定向放疗后的CT肺损伤及毒性模式
Br J Radiol. 2015 Apr;88(1048):20140728. doi: 10.1259/bjr.20140728. Epub 2015 Feb 3.
8
Computed tomography-based anatomic assessment overestimates local tumor recurrence in patients with mass-like consolidation after stereotactic body radiotherapy for early-stage non-small cell lung cancer.基于计算机断层扫描的解剖评估在立体定向体部放射治疗早期非小细胞肺癌后出现块状实变的患者中高估了局部肿瘤复发。
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1071-7. doi: 10.1016/j.ijrobp.2012.01.088. Epub 2012 Aug 14.
9
Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.非小细胞肺癌立体定向体部放疗后低分割放疗所致肋骨骨折:剂量与体积反应分析
Radiother Oncol. 2009 Jun;91(3):360-8. doi: 10.1016/j.radonc.2009.03.022. Epub 2009 May 4.
10
Lung metastases treated with image-guided stereotactic body radiation therapy.肺转移瘤采用图像引导立体定向放射治疗。
Clin Oncol (R Coll Radiol). 2013 Apr;25(4):236-41. doi: 10.1016/j.clon.2012.12.005. Epub 2013 Jan 24.

引用本文的文献

1
Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.不可手术的早期非小细胞肺癌中,失活预测快速复发。
JCO Precis Oncol. 2023 Jan;7:e2200273. doi: 10.1200/PO.22.00273.
2
3D deep convolution neural network for radiation pneumonitis prediction following stereotactic body radiotherapy.基于 3D 深度卷积神经网络的立体定向体部放疗后放射性肺炎预测
J Appl Clin Med Phys. 2023 Mar;24(3):e13875. doi: 10.1002/acm2.13875. Epub 2022 Dec 22.
3
Survival and Prognostic Factors of Ultra-Central Tumors Treated with Stereotactic Body Radiotherapy.
立体定向体部放疗治疗超中心肿瘤的生存及预后因素
Cancers (Basel). 2022 Nov 29;14(23):5908. doi: 10.3390/cancers14235908.
4
CT patterns and serial CT Changes in lung Cancer patients post stereotactic body radiotherapy (SBRT).肺癌患者立体定向体部放疗(SBRT)后的 CT 模式和连续 CT 变化。
Cancer Imaging. 2022 Sep 16;22(1):51. doi: 10.1186/s40644-022-00491-1.
5
Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer.循环 T 细胞激活和耗竭标志物与非小细胞肺癌的放射性肺炎及不良预后相关。
Front Immunol. 2022 Jul 14;13:875152. doi: 10.3389/fimmu.2022.875152. eCollection 2022.
6
Development of Radiographic Radiation Pneumonitis (RP) in Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy (SBRT) May Be Protective Against Further Disease Progression.接受立体定向体部放射治疗(SBRT)的非小细胞肺癌患者发生放射性肺炎(RP)可能对预防疾病进一步进展具有保护作用。
Cureus. 2022 Jun 16;14(6):e25994. doi: 10.7759/cureus.25994. eCollection 2022 Jun.
7
Modern evidence and future prospects of external body radiation therapy for lung oligometastases of breast cancer.乳腺癌肺寡转移体外放射治疗的现代证据与未来展望
Transl Cancer Res. 2020 Aug;9(8):5077-5086. doi: 10.21037/tcr.2020.02.55.
8
Single Institution Experience of Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer: Comparison of Two Dose Regimes and a Perspective on Ideal Dose Regimens.非小细胞肺癌立体定向体部放射治疗的单机构经验:两种剂量方案的比较及理想剂量方案的展望
Cureus. 2021 Oct 18;13(10):e18862. doi: 10.7759/cureus.18862. eCollection 2021 Oct.
9
Individualized Fraction Regimen of SBRT Patients With Non-Small Cell Lung Cancer Based on Uncomplicated and Cancer-Free Control Probability.基于无并发症和无癌控制概率的非小细胞肺癌 SBRT 患者个体化分割方案。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211011967. doi: 10.1177/15330338211011967.
10
The increasing potential of nuclear medicine imaging for the evaluation and reduction of normal tissue toxicity from radiation treatments.核医学成像在评估和降低放射性治疗正常组织毒性方面的潜力不断增加。
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3762-3775. doi: 10.1007/s00259-021-05284-5. Epub 2021 Mar 9.